skip to main | skip to sidebar

THE AMPYRA CHANNEL

NEWS & TIPS!

Sunday

Long-term safety and efficacy of Ampyra (dalfampridine) for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials: STUDY




















Read more »
Posted by Josi Creek YNergy at 7:33 PM
Labels: Clinical Trials, Fampyra, Study
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Blog Archive

  • ►  2016 (8)
    • ►  May (1)
    • ►  March (2)
    • ►  February (5)
  • ▼  2015 (16)
    • ►  July (1)
    • ►  June (3)
    • ▼  March (1)
      • Long-term safety and efficacy of Ampyra (dalfampri...
    • ►  February (1)
    • ►  January (10)
  • ►  2014 (42)
    • ►  April (41)
    • ►  February (1)
  • ►  2013 (12)
    • ►  October (7)
    • ►  September (2)
    • ►  July (2)
    • ►  May (1)
  • ►  2010 (26)
    • ►  May (1)
    • ►  April (13)
    • ►  March (12)